Teva_Pharmaceuticals | ערוץ 7
Teva Pharmaceuticals Lays Off Half Its Israeli Workers
TEVA: 3 Top-Rated Israeli Stocks to Add to Your Watchlist
Teva to pay NIS 75 million to Israel authorities to settle foreign bribe claims | The Times of Israel
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
FDA Requests More Data on Potential New Treatment for Huntington Disease
Teva to cut up to 1,700 jobs in streamlining plan — report | The Times of Israel
Teva looks to amp up research collaborations, CEO says
Teva to lay off 350 employees in Israel | ערוץ 7
Netanyahu adviser: Teva could leave Israel if gov't interferes in its business | The Times of Israel
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
Israel's Teva Pharm to start paying US opioid settlement in 2023 -CEO - The Jerusalem Post
Teva to Cut Up to 25% of Israel Workforce, Calcalist Says - Bloomberg
Teva Pharmaceuticals found liable for role in New York opioid epidemic - UPI.com
Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York Times
Teva Pharmaceutical Industries and opioid settlement: What to know
Teva shares plunge as competitors get nod for copycat flagship drug | The Times of Israel
Teva shed 37% of Israel workforce in two years - Globes
Teva Pharmaceuticals: Israeli drugmaker to cut 14,000 jobs - BBC News
Teva sells Overland Park business segment - Kansas City Business Journal
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN
Teva Pharmaceuticals - Wikipedia
Teva Pharmaceuticals Stock Jumps After Reporting Earnings. What You Need to Know. | Barron's
Teva bought the pharm, and now it may have bought the farm | The Times of Israel
Israeli Teva reaches proposed $4.35 bln settlement of US opioid lawsuits - The Jerusalem Post
Teva Pharmaceuticals CEO on the Covid-19 vaccine rollout in Israel
Teva Pharmaceutical in $4.35 opioid settlement with states, Native American tribes (TEVA) | Seeking Alpha
Israel's Teva gives upbeat outlook as restructuring proceeds
